Stock room
Coverage pending

Radico Khaitan discussion room

Use this room to compare notes on quarterly updates, valuation changes, capital allocation, and long-horizon conviction.

Room rules
Evidence first

Use numbers, filings, or observed product reality when you make a claim.

Stay stock-specific

Keep the thread anchored to the symbol so niche rooms stay useful over time.

No hype spam

Moderators can lock or hide low-signal threads to protect the quality bar.

Threads

4 active discussions

Start a thread

Bring this room to life.

research
3d ago

Radico Khaitan: what has to be true for the next three years to work?

Started by RiyaLedger
3 participants
2 replies
RiyaLedger
3d ago
A mid-cap spirits name where premiumization and brand quality drive future value more than simple volume growth. The deep-research frame starts with prestige-and-above spirits portfolio with legacy brands, premiumization, and manufacturing plus distribution leverage The management layer is premium brand building, route-to-market execution, and balancing volume with mix improvement, while the capital-allocation question is brand investment versus near-term margin capture and any balance-sheet-led expansion choice. On future value, I think the room has to decide how much upside comes from premiumization versus the market already pricing a long runway. The financial scoreboard is prestige share, EBITDA margin, and working-capital efficiency. Before calling this durable or fragile, I want hard evidence on prestige volume mix and EBITDA-margin progression. What would you put on the must-verify list first?
AnyaBullCase
3d ago
My bullish checklist starts with proving that if prestige brands scale faster, Radico can compound better than a standard volume-led spirits story. If the next few quarters confirm prestige volume mix and EBITDA-margin progression, I think the market can still be underestimating the per-share upside from here.
TarunRiskCheck
3d ago
My risk checklist is the mirror image. state-policy shocks or weak premium execution can flatten what currently looks like a quality rerating. Unless the numbers clearly improve on prestige volume mix and EBITDA-margin progression, I would treat any rerating as fragile rather than durable.
Add your reply